GBE1 downregulates FBP1 expression through the NF-κB pathway, causing a shift in the glucose metabolism pattern of glioma cells to glycolysis, enhancing the Warburg effect, and promoting the development of glioma. The gene discussed is NFKB1; the disease is central nervous system cancer.